Boothbay Fund Management, LLC Biotechnology

Boothbay Fund Management, LLC

  • $3.27 Billion
  • Q4 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
BPMC
Blueprint Medicines Corp
CALL
$12.2 Million
140K
Q4 2024
Added 99.05%
INSM
Insmed Inc
CALL
$9.44 Million
137K
Q4 2024
Reduced 22.67%
BBIO
Bridge Bio Pharma, Inc.
CALL
$5.57 Million
203K
Q4 2024
Reduced 24.47%
RVNC
Revance Therapeutics, Inc.
PUT
$4.79 Million
1.87M
Q4 2024
New holding
AXSM
Axsome Therapeutics, Inc.
CALL
$4.41 Million
52.1K
Q4 2021
New holding
RNA
Avidity Biosciences, Inc.
PUT
$3.38 Million
116K N/A
SRPT
Sarepta Therapeutics, Inc.
CALL
$2.85 Million
23.4K
Q4 2024
Reduced 35.73%
IMVT
Immunovant, Inc.
CALL
$2.53 Million
91.8K
Q2 2024
Reduced 0.34%
DYN
Dyne Therapeutics, Inc.
PUT
$1.92 Million
81.6K
Q4 2023
New holding
BGNE
Bei Gene, Ltd.
CALL
$1.68 Million
9.1K
Q4 2024
Added 30.68%
CLDX
Celldex Therapeutics, Inc.
PUT
$1.54 Million
60.9K
Q1 2023
Reduced 37.4%
VIR
Vir Biotechnology, Inc.
CALL
$1.52 Million
208K
Q4 2024
New holding
CAPR
Capricor Therapeutics, Inc.
CALL
$1.46 Million
105K
Q3 2024
New holding
VKTX
Viking Therapeutics, Inc.
CALL
$1.32 Million
32.7K
Q2 2024
Added 428.44%
SRRK
Scholar Rock Holding Corp
CALL
$1.27 Million
29.4K
Q4 2024
New holding
PRTA
Prothena Corp Public LTD CO
PUT
$1.27 Million
91.5K
Q4 2024
New holding
CAPR
Capricor Therapeutics, Inc.
PUT
$1.21 Million
87.7K
Q3 2024
New holding
MRNA
Moderna, Inc.
PUT
$1.2 Million
28.9K
Q2 2024
New holding
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$1.14 Million
219K
Q2 2022
Closed
VRDN
Viridian Therapeutics, Inc.\De
CALL
$983,000
51.3K
Q4 2024
Reduced 6.02%
RNA
Avidity Biosciences, Inc.
CALL
$854,000
29.4K N/A
QURE
Uni Qure N.V.
CALL
$754,000
42.7K
Q4 2024
Reduced 68.21%
CRVS
Corvus Pharmaceuticals, Inc.
PUT
$750,000
144K
Q2 2022
Closed
NVAX
Novavax Inc
CALL
$695,000
86.5K
Q4 2023
Reduced 46.49%
RCUS
Arcus Biosciences, Inc.
CALL
$611,000
41.1K
Q4 2024
Reduced 49.44%
BMEA
Biomea Fusion, Inc.
PUT
$488,000
126K
Q2 2023
Added 24.15%
GALT
Galectin Therapeutics Inc
CALL
$414,000
348K
Q4 2023
New holding
GALT
Galectin Therapeutics Inc
PUT
$414,000
348K
Q4 2023
New holding
RVNC
Revance Therapeutics, Inc.
CALL
$411,000
160K
Q4 2024
New holding
WVE
Wave Life Sciences Ltd.
CALL
$363,000
29.4K
Q4 2024
Reduced 64.7%
ALT
Altimmune, Inc.
PUT
$344,000
47.8K
Q1 2023
Added 236.63%
ALT
Altimmune, Inc.
CALL
$344,000
47.8K
Q1 2023
Added 236.63%
SANA
Sana Biotechnology, Inc.
CALL
$309,000
190K
Q4 2024
New holding
SANA
Sana Biotechnology, Inc.
PUT
$238,000
146K
Q4 2024
New holding
IMUX
Immunic, Inc.
CALL
$184,000
184K
Q4 2024
Added 0.42%
ABEO
Abeona Therapeutics Inc.
CALL
$103,000
18.6K
Q4 2024
Added 25.3%
SAVA
Cassava Sciences Inc
CALL
$91,000
38.6K
Q4 2023
New holding
Filter Shares Options
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email